Wheatcroft J, Wakelin D, Smith A, Mahoney C R, Mawe G, Spiller R
Wolfson Digestive Diseases Centre, University Hospital, Nottingham, UK.
Neurogastroenterol Motil. 2005 Dec;17(6):863-70. doi: 10.1111/j.1365-2982.2005.00719.x.
Patients with postinfective irritable bowel syndrome and Trichinella spiralis-infected mice share many features including visceral hypersensitivity and disordered motility. We assessed enterochromaffin (EC) numbers and serotonin transporter (SERT) using National Institute of Health (NIH) female mice studied for up to 56 days post-T. spiralis infection. The effects of steroid treatment and the T-cell dependence of the observed responses were assessed by infection of hydrocortisone-treated or T-cell receptor knock out [TCR (betaxdelta) KO] animals. Enterochromaffin cell density in uninfected animals increased from duodenum 10.0 cells mm-2 (5.9-41.0) to colon 61.8. (46.3-162) cells mm-2 P<0.0001. Infection increased duodenal and jejunal counts which rose to 37.3 (22-57.7) cells mm-2 and 50.6 (7-110.8) cells mm-2, respectively, at day 14. Infection significantly reduced jejunal SERT expression, with luminance values falling from 61.0 (45.1-98.3) to a nadir of 11.6 (0-36.0) units at day 9, P<0.001. Specific deficiencies in all T cells reduced EC hyperplasia and abrogated infection-induced mastocytosis. Thus infection induced inflammation increases EC numbers, as has been reported in PI-IBS, and reduces SERT. This may increase mucosal 5HT availability and contribute to the clinical presentation of PI-IBS.
感染后肠易激综合征患者和旋毛虫感染小鼠有许多共同特征,包括内脏超敏反应和运动紊乱。我们使用美国国立卫生研究院(NIH)的雌性小鼠评估了肠嗜铬(EC)细胞数量和5-羟色胺转运体(SERT),这些小鼠在旋毛虫感染后长达56天进行研究。通过对氢化可的松治疗的动物或T细胞受体敲除[TCR(βxδ)KO]动物进行感染,评估了类固醇治疗的效果以及观察到的反应对T细胞的依赖性。未感染动物的肠嗜铬细胞密度从十二指肠的10.0个细胞/mm²(5.9 - 41.0)增加到结肠的61.8个细胞/mm²(46.3 - 162),P<0.0001。感染使十二指肠和空肠的细胞计数增加,在第14天时分别升至37.3个细胞/mm²(22 - 57.7)和50.6个细胞/mm²(7 - 110.8)。感染显著降低了空肠SERT表达,亮度值从第9天的61.0(45.1 - 98.3)降至最低点11.6(0 - 36.0)单位,P<0.001。所有T细胞的特异性缺陷减少了EC细胞增生,并消除了感染诱导的肥大细胞增多。因此,感染诱导的炎症增加了EC细胞数量,这与PI - IBS中报道的情况一致,并降低了SERT。这可能会增加黏膜5-羟色胺的可用性,并导致PI - IBS的临床表现。